ARDT (Ardent Health) ROE %: 12.15% (As of Mar. 2026) — 25% Above Median


ARDT Ardent Health Inc ARDT
39 GF Score
Price $9.93
! 2 Warning Signs
View Full Analysis

What is Ardent Health ROE %?

Ardent Health ARDT +2.06% 39 ROE % is 12.15% as of Mar. 2026, which is 25% above its 10-year median of 9.73. GuruFocus rates ARDT with a GF Score™ of 39/100. The stock has 2 warning signs investors should review. Among 625 Healthcare Providers & Services companies, Ardent Health ranks better than 65.12% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Ardent Health's annualized net income for the quarter that ended in Mar. 2026 was $159 Mil. Ardent Health's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was $1,312 Mil. Therefore, Ardent Health's annualized ROE % for the quarter that ended in Mar. 2026 was 12.15%.

The historical rank and industry rank for Ardent Health's ROE % or its related term are showing as below:

ARDT' s ROE % Range Over the Past 10 Years
Min: -18.35   Med: 9.73   Max: 40.71
Current: 10.67

During the past 8 years, Ardent Health's highest ROE % was 40.71%. The lowest was -18.35%. And the median was 9.73%.

ARDT's ROE % is ranked better than
65.12% of 625 companies
in the Healthcare Providers & Services industry
Industry Median: 5.84 vs ARDT: 10.67

Ardent Health  (NYSE:ARDT) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=159.4/1312.3625
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(159.4 / 6407.48)*(6407.48 / 5271.5165)*(5271.5165 / 1312.3625)
=Net Margin %*Asset Turnover*Equity Multiplier
=2.49 %*1.2155*4.0168
=ROA %*Equity Multiplier
=3.03 %*4.0168
=12.15 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=159.4/1312.3625
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (159.4 / 298.364) * (298.364 / 323.648) * (323.648 / 6407.48) * (6407.48 / 5271.5165) * (5271.5165 / 1312.3625)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.5342 * 0.9219 * 5.05 % * 1.2155 * 4.0168
=12.15 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Ardent Health ROE % Related Terms


Ardent Health ROE % Historical Data

* Premium members only.

The historical data trend for Ardent Health's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ardent Health ROE % Chart

Ardent Health Annual Data
Trend Dec16 Dec17 Dec18 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial 40.71 29.56 8.23 23.34 11.23

Ardent Health Quarterly Data
Dec16 Dec17 Sep18 Dec18 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.35 24.02 -7.53 14.24 12.15

ARDT vs INNV, AMN, PNTG: ROE % Comparison

For the Medical Care Facilities subindustry, Ardent Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ardent Health ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ardent Health's ROE % distribution charts can be found below:

* The bar in red indicates where Ardent Health's ROE % falls into.


ARDT
39GF Score
Ardent Health Inc ARDT
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ardent Health ROE % Calculation

Ardent Health's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=135.811/( (1131.376+1287.898)/ 2 )
=135.811/1209.637
=11.23 %

Ardent Health's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=159.4/( (1287.898+1336.827)/ 2 )
=159.4/1312.3625
=12.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 12.15% mean?
Ardent Health (ARDT) has a ROE % of 12.15% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Ardent Health and its competitors. This is 25% above median its historical median of 9.73. According to the industry distribution chart, Ardent Health ranks #218 out of 625 companies in the Healthcare Providers & Services industry, placing it in the top 34.9%.
Is Ardent Health's ROE % too high?
Ardent Health's current ROE % of 12.15% is 25% above median its 10-year median of 9.73. The Healthcare Providers & Services industry median ROE % is 5.84. Ardent Health's value of 12.15% is 108% above this industry median. Based on the distribution chart, Ardent Health ranks #218 out of 625 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ardent Health has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Ardent Health's ROE % compare to INNV and AMN?
According to the Healthcare Providers & Services industry distribution chart, Ardent Health ranks #218 out of 625 companies for ROE %. This puts Ardent Health in the upper half of its industry. The industry median ROE % is 5.84. Ardent Health's value of 12.15% is 108% above this benchmark. While the company's 10-year median is 9.73 vs. the industry median of 5.84, Ardent Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.84, based on 625 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ardent Health's current ROE % of 12.15% is 108% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Ardent Health and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ardent Health's current ROE % is 12.15%, which is 25% above median its own 10-year median of 9.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ardent Health stock overvalued right now?
Ardent Health (ARDT) has a current ROE % of 12.15%. The current ROE % is 12.15%, which is 25% above median its 10-year median of 9.73 and 108% above the Healthcare Providers & Services industry median of 5.84. Ardent Health's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Ardent Health (ARDT), the current ROE % is 12.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ardent Health Business Description

Address 340 Seven Springs Way, Suite 100, Brentwood, TN, USA, 37027
Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S and operating in eight growing mid-sized urban markets across six states Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. The main focus on people and investments in services and technologies.
39GF Score

Get the complete analysis for ARDT

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.93
Price